I agree that this site is using cookies. You can find further informations here.
X
Azimpour, K.
22  results:
Search for persons X
?
1

PCR135 Humanistic Burden of Fabry Disease and Associated Ut..:

Azimpour, K ; Dorling, P ; Igbelina, CD..
Value in Health.  27 (2024)  6 - p. S320-S321 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EE309 Cost-Effectiveness Analysis of Velmanase Alfa in Pati..:

Stevenson, A ; Chang-Douglass, S. ; Kazmierska, P...
Value in Health.  27 (2024)  6 - p. S114 , 2024
Link: https://doi.org/10.1016/..
 
?
3

EE527 A Systematic Literature Review of the Economic Burden..:

Azimpour, K. ; Dorling, P. ; Igbelina, C.D..
Value in Health.  26 (2023)  6 - p. S156 , 2023
Link: https://doi.org/10.1016/..
 
?
4

PCR86 Estimating Health-Related Quality of Life in Fabry Di..:

Lee, B. ; Hemstock, M. ; Stevenson, A...
Value in Health.  26 (2023)  12 - p. S465 , 2023
Link: https://doi.org/10.1016/..
 
?
5

PCR143 European Quality of Life Five Dimension (EQ-5D) Util..:

Azimpour, K. ; Dorling, P. ; Koulinska, I....
Value in Health.  26 (2023)  12 - p. S476 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EE64 Impact of Baseline Characteristics on Indirect Treatme..:

Azimpour, K. ; Tordoff-Gibson, C. ; Dorling, P....
Value in Health.  26 (2023)  6 - p. S71 , 2023
Link: https://doi.org/10.1016/..
 
?
7

HTA34 The Role of the Mainz Severity Score Index (MSSI) on ..:

Cha, E ; Kim, E ; Musat, M..
Value in Health.  25 (2022)  7 - p. S509-S510 , 2022
Link: https://doi.org/10.1016/..
 
?
8

HTA65 The Relationship between Globotriaosylceramide (GB3),..:

Azimpour, K ; Kim, E ; Musat, M..
Value in Health.  25 (2022)  7 - p. S515 , 2022
Link: https://doi.org/10.1016/..
 
?
9

EE148 Canadian Cost-Effectiveness Analysis of Deferiprone C..:

Azimpour, K ; Ramjee, L ; Tremblay, G.
Value in Health.  25 (2022)  12 - p. S82 , 2022
Link: https://doi.org/10.1016/..
 
?
10

HTA48 Minimum Follow-up Time Required for the Detection of ..:

Cha, E ; Azimpour, K ; Musat, M...
Value in Health.  25 (2022)  7 - p. S512-S513 , 2022
Link: https://doi.org/10.1016/..
 
?
11

HTA49 Determining Appropriate Health Economic Modeling Appr..:

Azimpour, K ; Cha, E ; Hwang, S..
Value in Health.  25 (2022)  7 - p. S513 , 2022
Link: https://doi.org/10.1016/..
 
?
12

PCN104 The Appropriate Health Economic Modeling Approach in..:

Azimpour, K. ; Tremblay, G. ; Wolitski, D..
Value in Health.  24 (2021)  - p. S39 , 2021
Link: https://doi.org/10.1016/..
 
?
13

PCN256 GLOBAL ONCOLOGY ACCESS - THE RELATIVE DIFFICULTY OF ..:

Nguyen, K. ; Forsythe, A. ; Azimpour, K...
Value in Health.  23 (2020)  - p. S68 , 2020
Link: https://doi.org/10.1016/..
 
?
14

PIN38 COST-EFFECTIVENESS OF TESAMORELIN IN THE TREATMENT OF..:

Azimpour, K. ; Tremblay, G. ; de Chantal, M..
Value in Health.  23 (2020)  - p. S175 , 2020
Link: https://doi.org/10.1016/..
 
?
15

PMS25 CLINICAL VALIDATION OF A BUDGET IMPACT MODEL USING TH..:

Tremblay, G. ; Azimpour, K. ; Groff, M.
Value in Health.  23 (2020)  - p. S219 , 2020
Link: https://doi.org/10.1016/..
 
1-15